跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOFILEX FOR ORAL SUSPENSION 125 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
SOFILEX FOR ORAL SUSPENSION 125 MG/5 ML
Approved
THERAPEUTIC
SOFILEX FOR ORAL SUSPENSION 125 MG/5 ML
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 16, 1998
Approval ID
fd7beffe5bbb2c2b
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
fd7beffe5bbb2c2b
Drug Name
SOFILEX FOR ORAL SUSPENSION 125 MG/5 ML
Product Name
SOFILEX FOR ORAL SUSPENSION 125 MG/5 ML
Approval Number
SIN10419P
Approval Date
1998-11-16
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01DB01
Atc Item Name
cefalexin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
CEPHALEXIN
125 mg/5 ml
CEPHALEXIN
125 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 16, 1998
Approval ID
fd7beffe5bbb2c2b
Type
Therapeutic
Back to HSA Approvals